The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer
Shaw, A. T., Kim, D.-W., Nakagawa, K., Seto, T., Crinó, L., Ahn, M.-J., De Pas, T., Besse, B., Solomon, B. J., Blackhall, F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214886 · Cited by 3,381
First-Line Crizotinib versus Chemotherapy in ALK -Positive Lung Cancer
Solomon, B. J., Mok, T., Kim, D.-W., Wu, Y.-L., Nakagawa, K., Mekhail, T., Felip, E., Cappuzzo, F., Paolini, J., Usari, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408440 · Cited by 3,190
Chang, E. L., Wefel, J. S., Hess, K. R., Allen, P. K., Lang, F. F., Kornguth, D. G., Arbuckle, R. B., Swint, J. M., Shiu, A. S., Maor, M. H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70263-3 · Cited by 2,475
Aoyama, H., Shirato, H., Tago, M., Nakagawa, K., Toyoda, T., Hatano, K., Kenjyo, M., Oya, N., Hirota, S., Shioura, H., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2483 · Cited by 2,213
The management of brain metastases
Patchell, R. A. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)00105-1 · Cited by 654
Costa, D. B., Shaw, A. T., Ou, S.-H. I., Solomon, B. J., Riely, G. J., Ahn, M.-J., Zhou, C., Shreeve, S. M., Selaru, P., Polli, A., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.0539 · Cited by 599
Welsh, J. W., Komaki, R., Amini, A., Munsell, M. F., Unger, W., Allen, P. K., Chang, J. Y., Wefel, J. S., McGovern, S. L., Garland, L. L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.1174 · Cited by 395
Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trial
Ceresoli, G. L., Cappuzzo, F., Gregorc, V., Bartolini, S., Crinò, L., & Villa, E. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh276 · Cited by 349
Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis.
Sørensen, J. B., Hansen, H. H., Hansen, M., & Dombernowsky, P. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.9.1474 · Cited by 339
Current approaches to the treatment of metastatic brain tumours
Owonikoko, T. K., Arbiser, J., Zelnak, A., Shu, H.-K. G., Shim, H., Robin, A. M., Kalkanis, S. N., Whitsett, T. G., Salhia, B., Tran, N. L., et al. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.25 · Cited by 304
Sperduto, P. W., Wang, M., Robins, H. I., Schell, M. C., Werner-Wasik, M., Komaki, R., Souhami, L., Buyyounouski, M. K., Khuntia, D., Demas, W., et al. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.11.042 · Cited by 274
EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer
Eichler, A. F., Kahle, K. T., Wang, D. L., Joshi, V. A., Willers, H., Engelman, J. A., Lynch, T. J., & Sequist, L. V. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq076 · Cited by 263
Barlesi, F., Gervais, R., Lena, H., Hureaux, J., Berard, H., Paillotin, D., Bota, S., Monnet, I., Chajara, A., & Robinet, G. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr003 · Cited by 240
Wu, Y.-L., Zhou, C., Cheng, Y., Lu, S., Chen, G.-Y., Huang, C., Huang, Y.-S., Yan, H.-H., Ren, S., Liu, Y., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds529 · Cited by 234
Ou, S.-H. I., Jänne, P. A., Bartlett, C. H., Tang, Y., Kim, D.-W., Otterson, G. A., Crinò, L., Selaru, P., Cohen, D. P., Clark, J. W., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdt572 · Cited by 219
Phase III Study of Efaproxiral As an Adjunct to Whole-Brain Radiation Therapy for Brain Metastases
Suh, J. H., Stea, B., Nabid, A., Kresl, J. J., Fortin, A., Mercier, J.-P., Senzer, N., Chang, E. L., Boyd, A. P., Cagnoni, P. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.1768 · Cited by 195
Mehta, M. P., Shapiro, W. R., Phan, S. C., Gervais, R., Carrie, C., Chabot, P., Patchell, R. A., Glantz, M. J., Recht, L., Langer, C., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.05.068 · Cited by 164
Gefitinib as palliative therapy for lung adenocarcinoma metastatic to the brain
Wu, C., Li, Y. L., Wang, Z. M., Li, Z., Zhang, T. X., & Wei, Z. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.03.011 · Cited by 148
Zimmermann, S., Dziadziuszko, R., & Peters, S. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.03.005 · Cited by 147
Self-citationGow, C.-H., Chien, C.-R., Chang, Y.-L., Chiu, Y.-H., Kuo, S.-H., Shih, J.-Y., Chang, Y.-C., Yu, C.-J., Yang, C.-H., & Yang, P.-C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1468 · Cited by 146
Chiu, C., Tsai, C., Chen, Y., Chiang, S.-C., Liou, J.-L., & Perng, R.-P. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.05.014 · Cited by 141
Symptom response after palliative radiotherapy for patients with brain metastases
Bezjak, A., Adam, J., Barton, R., Panzarella, T., Laperrière, N., Wong, C. S., Mason, W. P., Buckley, C., Levin, W., McLean, M., et al. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00150-2 · Cited by 134
Bernardo, G. D., Cuzzoni, Q., Strada, M. R., Bernardo, A., Brunetti, G., Jedrychowska, I., Pozzi, U., & Palumbo, R. (2002) · Cancer Investigation · doi:10.1081/cnv-120001173 · Cited by 134
Lin, N., Lee, E. Q., Aoyama, H., Barani, I. J., Baumert, B. G., Brown, P. D., Camidge, D. R., Chang, S. M., Dancey, J. E., Gaspar, L. E., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70311-5 · Cited by 132
Ma, S., Xu, Y., Deng, Q., & Yu, X. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.10.028 · Cited by 127
Chow, E., Davis, L., Holden, L., Tsao, M. N., & Danjoux, C. E. (2005) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2005.02.009 · Cited by 126
Soon, Y. Y., Leong, C. N., Koh, W. Y., & Tham, I. W. K. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.12.011 · Cited by 110 · cited 2×
“1); 80 [50–100]; 70–90 Salvage SRS (N = 14): 79.”
BackgroundGuérin, A., Sasané, M., Zhang, J., Culver, K. W., Dea, K., Nitulescu, R., & Wu, E. Q. (2015) · Journal of Medical Economics · doi:10.3111/13696998.2014.1003644 · Cited by 103
Siena, S., Crinò, L., Danova, M., Prete, S. D., Cascinu, S., Salvagni, S., Schiavetto, I., Vitali, M., & Bajetta, E. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp343 · Cited by 102
Brain Metastases in NSCLC - are TKIs Changing the Treatment Strategy?
Dempke, W. C. M., Edvardsen, K., Lü, S., Reinmuth, N., Reck, M., & Inoue, A. (2015) · PubMed · Cited by 102
Guerrieri, M., Wong, K., Ryan, G. F., Millward, M. J., Quong, G., & Ball, D. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.02.019 · Cited by 100
Lim, S. H., Lee, J. Y., Lee, M.-Y., Kim, H. S., Lee, J. H., Sun, J., Ahn, J. S., Um, S., Kim, H., Kim, B. S., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu584 · Cited by 93
Addeo, R., Caraglia, M., Faiola, V., Capasso, E., Vincenzi, B., Montella, L., Guarrasi, R., Caserta, L., & Prete, S. D. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-18 · Cited by 76
Wong, J., Hird, A. E., Zhang, L., Tsao, M. N., Sinclair, E., Barnes, E. A., Danjoux, C. E., & Chow, E. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.12.013 · Cited by 72
Giorgio, C. G., Giuffrida, D., Pappalardo, A., Russo, A. D., Santini, D., Salice, P., Blanco, G., Castorina, S., Failla, G., & Bordonaro, R. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.05.026 · Cited by 70
Halasz, L. M., Weeks, J. C., Neville, B. A., Taback, N., & Punglia, R. S. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.08.007 · Cited by 67
Gamma Knife radiosurgery for the management of cerebral metastases from non–small cell lung cancer
Bowden, G. N., Kano, H., Caparosa, E. M., Park, S., Niranjan, A., Flíckinger, J. C., & Lunsford, L. D. (2015) · Journal of neurosurgery · doi:10.3171/2014.12.jns141111 · Cited by 63
Dinglin, X.-X., Huang, Y., Liu, H., Zeng, Y.-D., Hou, X., & Chen, L.-K. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1079-5 · Cited by 60
Temporal and gender-related trends in brain metastases from lung and breast cancer.
Yawn, B. P., Wollan, P. C., Schroeder, C., Gazzuola, L., & Mehta, M. P. (2003) · PubMed · Cited by 56
Novello, S., Camps, C., Grossi, F., Mazières, J., Abrey, L. E., Vernejoux, J.-M., Thall, A. D., Patyna, S. J., Usari, T., Wang, Z., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318219a973 · Cited by 48
Bhatt, V. R., Kedia, S., Kessinger, A., & Ganti, A. K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.8915 · Cited by 43
Cai, L., Zhu, J., Zhang, X., Lin, S.-X., Su, X., Lin, P., Chen, K., & Zhang, L. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1570-7 · Cited by 41
Edelman, M. J., Belani, C. P., Socinski, M. A., Ansari, R., Obasaju, C. K., Chen, R., Monberg, M., & Treat, J. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181c59a3a · Cited by 38
Shaw, A. T., Mehra, R., Tan, D. S. W., Felip, E., Chow, L. Q. M., Camidge, D. R., Vansteenkiste, J., Sharma, S., Pas, T. M. D., Riely, G. J., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu349.72 · Cited by 34
Ou, S. I., Ahn, J. S., Petris, L. D., Govindan, R., Yang, J. C., Hughes, B. G. M., Léna, H., Moro‐Sibilot, D., Bearz, A., Viteri, S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.33.15_suppl.8008 · Cited by 30
Mulvenna, P., Nankivell, M. G., Barton, R., Finn, C. F., Wilson, P., MOORE, B. J., McColl, E., Brisbane, I., Ardron, D., Sydes, B., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.33.15_suppl.8005 · Cited by 29
Grønberg, B. H., Ciuleanu, T., Fløtten, Ø., Knuuttila, A., Abel, E., Langer, S. W., Krejcy, K., Liepa, A. M., Muñoz, M. D. M., Hahka‐Kemppinen, M., et al. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.07.007 · Cited by 23
Ge, X., Lin, Q., Ren, X.-C., Liu, Y.-E., Chen, X., Wang, D., Wang, Y., Cao, B., Li, Z.-G., & Liu, M. (2013) · Radiation Oncology · doi:10.1186/1748-717x-8-238 · Cited by 19
Galetta, D., Gebbia, V., Silvestris, N., Ferraù, F., Carrozza, F., Cigolari, S., Russo, P., Calista, F., Adamo, V., & Colucci, G. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.07.013 · Cited by 16
Cited by
Osimertinib in Resected EGFR -Mutated Non–Small-Cell Lung Cancer
Wu, Y.-L., Tsuboi, M., He, J., John, T., Grohe, C., Majem, M., Goldman, J. W., Laktionov, K., Kim, S.-W., Kato, T., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2027071 · Cited by 1,798
Reungwetwattana, T., Nakagawa, K., Cho, B. C., Cobo, M., Cho, E. K., Bertolini, A., Bohnet, S., Zhou, C., Lee, K. H., Nogami, N., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.3118 · Cited by 811
Self-citationOsimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC
Planchard, D., Jänne, P. A., Cheng, Y., Yang, J. C.-H., Yanagitani, N., Kim, S.-W., Sugawara, S., Yu, Y., Fan, Y., Geater, S. L., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2306434 · Cited by 740
Overall Survival with Osimertinib in Resected EGFR -Mutated NSCLC
Tsuboi, M., Herbst, R. S., John, T., Kato, T., Majem, M., Grohé, C., Wang, J., Goldman, J. W., Lu, S., Su, W.-C., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2304594 · Cited by 672
Herbst, R. S., Wu, Y.-L., John, T., Grohe, C., Majem, M., Wang, J., Kato, T., Goldman, J. W., Laktionov, K., Kim, S.-W., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.02186 · Cited by 408
Metadata
- Authors
- Peters, S., Bexelius, C., Munk, V., & Leighl, N.
- Venue
- Cancer Treatment Reviews
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 45
- Pages
- 139-162
- ISSN
- 0305-7372 (ISSN-L)
- OpenAlex
- W2300932108
- Cited by
- 295
- References
- 51
- FWCI
- 17.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.